Literature DB >> 31455522

Measuring TREX1 and TREX2 exonuclease activities.

Wayne O Hemphill1, Fred W Perrino2.   

Abstract

Three-prime Repair Exonuclease (TREX1) degrades ssDNA and dsDNA. TREX1 localizes to the perinuclear space in cells and degrades cytosolic DNA to prevent aberrant nucleic acid sensing and immune activation in humans and mice. Mutations in the TREX1 gene cause a spectrum of human autoimmune diseases including Aicardi-Goutières syndrome, familial chilblain lupus, retinal vasculopathy with cerebral leukodystrophy, and are associated with systemic lupus erythematosus. More than 60 disease-causing TREX1 variants have been identified including dominant and recessive, missense, and frameshift mutations that map to the catalytic core region and to the C-terminal cell localization region. The TREX1-disease causing mutations affect exonuclease activity at varied levels. In this chapter, we describe methods to purify variant recombinant TREX1 enzymes and measure the exonuclease activity using ssDNA and dsDNA substrates. The relationships between TREX1 activities, types of TREX1 mutations, and TREX1-associated autoimmune diseases are considered.
© 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoimmunity; Exonuclease; TREX1; TREX2; dsDNA; ssDNA

Year:  2019        PMID: 31455522      PMCID: PMC6893858          DOI: 10.1016/bs.mie.2019.05.004

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  26 in total

1.  Excision of 3' termini by the Trex1 and TREX2 3'-->5' exonucleases. Characterization of the recombinant proteins.

Authors:  D J Mazur; F W Perrino
Journal:  J Biol Chem       Date:  2001-03-06       Impact factor: 5.157

2.  The TREX1 exonuclease R114H mutation in Aicardi-Goutières syndrome and lupus reveals dimeric structure requirements for DNA degradation activity.

Authors:  Clinton D Orebaugh; Jason M Fye; Scott Harvey; Thomas Hollis; Fred W Perrino
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

3.  The TREX1 double-stranded DNA degradation activity is defective in dominant mutations associated with autoimmune disease.

Authors:  Duane A Lehtinen; Scott Harvey; Matthew J Mulcahy; Thomas Hollis; Fred W Perrino
Journal:  J Biol Chem       Date:  2008-09-18       Impact factor: 5.157

4.  TREX1 D18N mice fail to process erythroblast DNA resulting in inflammation and dysfunctional erythropoiesis.

Authors:  Stephen L Rego; Scott Harvey; Sean R Simpson; Wayne O Hemphill; Zachariah A McIver; Jason M Grayson; Fred W Perrino
Journal:  Autoimmunity       Date:  2018-11-13       Impact factor: 2.815

Review 5.  Human disease phenotypes associated with mutations in TREX1.

Authors:  Gillian I Rice; Mathieu P Rodero; Yanick J Crow
Journal:  J Clin Immunol       Date:  2015-03-04       Impact factor: 8.317

6.  DNase-active TREX1 frame-shift mutants induce serologic autoimmunity in mice.

Authors:  Tomomi Sakai; Takuya Miyazaki; Dong-Mi Shin; Yong-Soo Kim; Chen-Feng Qi; Robert Fariss; Jeeva Munasinghe; Hongsheng Wang; Alexander L Kovalchuk; Parul H Kothari; Charles S Fermaintt; John P Atkinson; Fred W Perrino; Nan Yan; Herbert C Morse
Journal:  J Autoimmun       Date:  2017-03-18       Impact factor: 7.094

7.  Identification of a 3'-->5'-exonuclease that removes cytosine arabinoside monophosphate from 3' termini of DNA.

Authors:  F W Perrino; H Miller; K A Ealey
Journal:  J Biol Chem       Date:  1994-06-10       Impact factor: 5.157

8.  Cytosolic Nuclease TREX1 Regulates Oligosaccharyltransferase Activity Independent of Nuclease Activity to Suppress Immune Activation.

Authors:  Maroof Hasan; Charles S Fermaintt; Ningguo Gao; Tomomi Sakai; Takuya Miyazaki; Sixin Jiang; Quan-Zhen Li; John P Atkinson; Herbert C Morse; Mark A Lehrman; Nan Yan
Journal:  Immunity       Date:  2015-08-25       Impact factor: 31.745

9.  A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus.

Authors:  Min Ae Lee-Kirsch; Dipanjan Chowdhury; Scott Harvey; Maoliang Gong; Lydia Senenko; Kerstin Engel; Christiane Pfeiffer; Thomas Hollis; Manfred Gahr; Fred W Perrino; Judy Lieberman; Norbert Hubner
Journal:  J Mol Med (Berl)       Date:  2007-04-18       Impact factor: 5.606

10.  Multifaceted role of TREX2 in the skin defense against UV-induced skin carcinogenesis.

Authors:  Joan Manils; Diana Gómez; Mercè Salla-Martret; Heinz Fischer; Jason M Fye; Elena Marzo; Laura Marruecos; Inma Serrano; Rocío Salgado; Juan P Rodrigo; Juana M Garcia-Pedrero; Anna M Serafin; Xavier Cañas; Carmen Benito; Agustí Toll; Sònia-Vanina Forcales; Fred W Perrino; Leopold Eckhart; Concepció Soler
Journal:  Oncotarget       Date:  2015-09-08
View more
  3 in total

1.  TREX1 as a Novel Immunotherapeutic Target.

Authors:  Wayne O Hemphill; Sean R Simpson; Mingyong Liu; Freddie R Salsbury; Thomas Hollis; Jason M Grayson; Fred W Perrino
Journal:  Front Immunol       Date:  2021-04-01       Impact factor: 7.561

2.  Human TDP1, APE1 and TREX1 repair 3'-DNA-peptide/protein cross-links arising from abasic sites in vitro.

Authors:  Xiaoying Wei; Zhishuo Wang; Caroline Hinson; Kun Yang
Journal:  Nucleic Acids Res       Date:  2022-04-22       Impact factor: 19.160

3.  Genotype-Phenotype Correlation and Functional Insights for Two Monoallelic TREX1 Missense Variants Affecting the Catalytic Core.

Authors:  Giulia Amico; Wayne O Hemphill; Mariasavina Severino; Claudio Moratti; Rosario Pascarella; Marta Bertamino; Flavia Napoli; Stefano Volpi; Francesca Rosamilia; Sara Signa; Fred Perrino; Marialuisa Zedde; Isabella Ceccherini
Journal:  Genes (Basel)       Date:  2022-06-30       Impact factor: 4.141

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.